CONSTRUCTIVE BIO Trademark

Trademark Overview

On Thursday, September 26, 2024, a trademark application was filed for CONSTRUCTIVE BIO with the United States Patent and Trademark Office. The USPTO has given the CONSTRUCTIVE BIO trademark a serial number of 98771525. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, September 23, 2025. This trademark is owned by Constructive Biology Limited. The CONSTRUCTIVE BIO trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of amino acids; biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of hydroxy acids; biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of amino acids and hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of amino acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of amino acids and hydroxy acids.

Pharmaceuticals preparations for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquiliser...

Nucleic acid sequences, other than for medical or veterinary purposes; artificial nucleic acid sequences, other than for medical or veterinary purposes; amino acid sequences, other than for medical or veterinary purposes; artificial amino acid sequences, other than for medical or veterinary purposes; enzymes for industrial purposes; enzymes for scientific purposes; proteins for industrial purposes; bacterial preparations for industrial use, other than for medical or veterinary purposes; biopolymers, namely, unprocessed polymers of amino acids and hydroxy acids; biopolymers, namely, unprocessed polymers of amino acids; biopolymers, namely, unprocessed polymers of hydroxy acids; biomolecules, namely amino acids, other than for medical or veterinary purposes; biomolecules, namely hydroxy acids, other than for medical or veterinary purposes; biomolecules, namely amino acids and hydroxy acids, other than for medical or veterinary purposes; bioplastics in the nature of unprocessed plastics t...

Scientific research relating to medicines; scientific research relating to proteins and amino acid sequences for industrial and medical purposes; research and development in the pharmaceutical and biotechnology fields; scientific research and development for the pharmaceutical industry; scientific research and development in the field of biomaterials; scientific design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; scientific research in the field of DNA synthesis; scientific research in the field of protein synthesis; DNA sequencing technology research; bioplastics technology research; drug discovery services; research in the field of bioinformatics relating to design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; scientific research relating to genetic code expansion.
constructive bio

General Information

Serial Number98771525
Word MarkCONSTRUCTIVE BIO
Filing DateThursday, September 26, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, September 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of amino acids; biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of hydroxy acids; biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of amino acids and hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of amino acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of amino acids and hydroxy acids.
Goods and ServicesPharmaceuticals preparations for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders; biotechnological preparations for medical and veterinary use, namely, biotechnological pharmaceutical preparations in the form of fluid extracts for medicinal uses, pills, medicated tablets, compressed medicinal lozenges, elixirs, syrups for medicinal preparations, medicinal cordials, solid extracts, powdered extracts, concentrations, filled capsules and medicinal compounds in solid and liquid form for the treatment of diabetes, diarrhea, fungal infections/conditions, hypertension, inflammation, arthritis, helminth infections, cardiovascular conditions, allergies, dermatological conditions, gynaecological conditions, haematological conditions, metabolic conditions, nausea and vertigo, oncological diseases and disorders, cancer and tumours; biopharmaceuticals for medical and veterinary use, namely, biopharmaceutical preparations for human and veterinary purposes including namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders; enzymes for medical purposes; enzymes for veterinary purposes; bacterial preparations for medical purposes; bacterial preparations for veterinary purposes; antibodies for medical purposes; antibody-drug conjugates in the nature of antibodies for medical purposes; proteins for medical purposes, namely, for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being protein based; nucleic acid sequences for medical and veterinary purposes; peptides for medical and veterinary purposes, namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being peptide based; polypeptides containing non-proteinogenic amino acids for medical and veterinary purposes namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being non-proteinogenic amino acid polypeptide based; polypeptides containing non-canonical amino acids for medical and veterinary purposes namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being non-canonical amino acid polypeptide based.
Goods and ServicesNucleic acid sequences, other than for medical or veterinary purposes; artificial nucleic acid sequences, other than for medical or veterinary purposes; amino acid sequences, other than for medical or veterinary purposes; artificial amino acid sequences, other than for medical or veterinary purposes; enzymes for industrial purposes; enzymes for scientific purposes; proteins for industrial purposes; bacterial preparations for industrial use, other than for medical or veterinary purposes; biopolymers, namely, unprocessed polymers of amino acids and hydroxy acids; biopolymers, namely, unprocessed polymers of amino acids; biopolymers, namely, unprocessed polymers of hydroxy acids; biomolecules, namely amino acids, other than for medical or veterinary purposes; biomolecules, namely hydroxy acids, other than for medical or veterinary purposes; biomolecules, namely amino acids and hydroxy acids, other than for medical or veterinary purposes; bioplastics in the nature of unprocessed plastics that derive from biological sources; synthetic bacteria for use in the manufacture of polymers and materials comprising amino acids; synthetic bacteria for use in the manufacture of polymers and materials comprising hydroxy acids; synthetic bacteria for use in the manufacture of polymers and materials comprising nucleic acid sequences; recoded bacterial genomes, namely, nucleic acid sequences with a modified genetic code that differs from the genetic code of the native species, other than for medical or veterinary purposes; synthetic eukaryotic cells in the nature of mammalian, plant, yeast or other eukaryotic cells with a synthetic genome for scientific, laboratory or medical research; recoded eukaryotic genomes namely, nucleic acid sequences with a modified genetic code that differs from that of the native species, other than for medical or veterinary purposes; reagents for research purposes; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising amino acids; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising hydroxy acids; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising nucleic acid sequences;biochemical preparations in the nature of polypeptides containing non-proteinogenic amino acids for industrial purposes; biochemical preparations in the nature of polypeptides containing non-proteinogenic amino acids for scientific purposes; biochemical preparations in the nature of polypeptides containing non-canonical amino acids for industrial purposes; biochemical preparations in the nature of polypeptides containing non-canonical amino acids for scientific purposes.
NOT AVAILABLEBIO
Goods and ServicesScientific research relating to medicines; scientific research relating to proteins and amino acid sequences for industrial and medical purposes; research and development in the pharmaceutical and biotechnology fields; scientific research and development for the pharmaceutical industry; scientific research and development in the field of biomaterials; scientific design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; scientific research in the field of DNA synthesis; scientific research in the field of protein synthesis; DNA sequencing technology research; bioplastics technology research; drug discovery services; research in the field of bioinformatics relating to design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; scientific research relating to genetic code expansion.

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, September 26, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, September 23, 2025
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 26, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameConstructive Biology Limited
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressLondon WC1N3AX
GB

Trademark Events

Event DateEvent Description
Thursday, September 26, 2024NEW APPLICATION ENTERED
Thursday, September 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 27, 2025NON-FINAL ACTION E-MAILED
Thursday, March 27, 2025NON-FINAL ACTION WRITTEN
Monday, June 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 19, 2025ASSIGNED TO EXAMINER
Thursday, March 27, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 26, 2025NON-FINAL ACTION E-MAILED
Thursday, June 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 26, 2025NON-FINAL ACTION WRITTEN

Related Keywords

constructive acids sequences purposes acid amino preparations medical research nucleic pharmaceutical